Investigating the role of muscle myosin and shared pathogenetic mechanisms in neuromuscular disorders through in-depth single-fibre studies

Description of the granted funding

There is an increasing awareness in the clinical and scientific communities concerning the importance and need of a detailed understanding of muscle disorders, now being more efficiently diagnosed than before. Understanding the disease mechanisms is a pre-requisite for finding novel therapeutic options. In muscle disease patients, the day-to-day activities rapidly cause fatigue in the muscles, and recovery times are long. To date, no cure exists. The aim of our research group at the Folkhälsan Research Center is to shed light on the disease mechanisms, enabling us to connect the genetics to the clinical severity and course of the disease. We use novel single muscle-fibre methods, serving as a platform for finding new therapeutic targets and identifying patients who would benefit from a specific therapy. Our group is well connected for preparation of therapeutic trials, providing a possibility of direct implementation of therapies deemed to be safe and potentially efficient.
Show more

Starting year

2025

End year

2029

Granted funding

Jenni Laitila Orcid -palvelun logo
520 651 €

Funder

Research Council of Finland

Funding instrument

Academy research fellows

Decision maker

Scientific Council for Biosciences, Health and the Environment
16.06.2025

Other information

Funding decision number

369939

Fields of science

Genetics, developmental biology, physiology

Research fields

Perinnöllisyystiede